NCT05750719View on ClinicalTrials.gov

BRCA and NACT in TNBC Patients

CompletedOBSERVATIONAL
Enrollment

136

Participants

Timeline

Start Date

January 2, 2013

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Triple-Negative Breast Cancer
Interventions
GENETIC

BRCA1/2 genetic testing

All patients will undergo genetic testing for BRCA 1 and BRCA 2 germline mutations, employing next generation sequencing (NGS) techniques.

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05750719 - BRCA and NACT in TNBC Patients | Biotech Hunter | Biotech Hunter